Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

E-ISSN： 1097-0142|121|19|3444-3451

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.19, 2015-10, pp. : 3444-3451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beta-blockers in epithelial ovarian cancer

By Venniyoor Ajit

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 161-161

Blackwell Publishing

Access to resources Recommend Favorite

Are beta-blockers on the therapeutic horizon for ovarian cancer treatment?

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3380-3383

Blackwell Publishing

Access to resources Recommend Favorite

Clinical Relevance of Differences between Various Beta-Blockers

Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. : 11-13

Karger

Access to resources Recommend Favorite

Additional Features of Beta-Blockers

Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. : 6-10

Karger

Access to resources Recommend Favorite

Long-Term Treatment with Angiotensin-Converting Enzyme Inhibitors, Beta-Blockers or a Combination of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Low-Risk Patients after Acute Myocardial Infarction: The ABC Study

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 20-25

Karger

Access to resources Recommend Favorite